Please select the option that best describes you:

How would you manage new symptomatic brain metastases (10-15) in a young woman with HER2+ metastatic breast cancer?  

Controlled extracranial disease on trastuzumab+pertuzumab for 2 years. Treatment options include Enhertu or WBRT. Not a candidate for SRS or neurosurgery.



Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at Stroger Hospital
Absolutely agree
Sign in or Register to read more